StockData
MeiraGTx Holdings plc logo

MeiraGTx Holdings plc (MGTX) stock

MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.46−0.28 (-3.20%)

Close on Nov 17, 2026Market cap $812.52MP/E 11.9Yield –

Earnings

MeiraGTx's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 25, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
– on a year earlier
EPS, Q3 FY2026
-$0.53
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of MeiraGTx's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 25, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 12, 2026before the open––-$0.53Release
Q2 FY2026ended Jun 30, 2026Aug 13, 2026before the open––$1.71Release
Q1 FY2026ended Mar 31, 2026May 14, 2026before the open$300.00K-84.2%-$0.57Release
Q4 FY2025ended Dec 31, 2025Mar 26, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 13, 2025before the open$400.00K––Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025before the open$3.70M+1133.3%–Release
Q1 FY2025ended Mar 31, 2025May 13, 2025before the open$1.90M––Release
Q4 FY2024ended Dec 31, 2024Mar 13, 2025before the open–––Release
Q3 FY2024ended Sep 30, 2024Nov 13, 2024before the open–––Release
Q2 FY2024ended Jun 30, 2024Aug 12, 2024before the open$300.00K-91.4%-$0.76Release
Q1 FY2024ended Mar 31, 2024May 9, 2024before the open––-$0.32Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

MeiraGTx has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When MeiraGTx puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases MeiraGTx filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Results
  4. Update
  5. Results
  6. Update
  7. Update
  8. Update
  9. Results
  10. Results
  11. Update
  12. Results
  13. Results
  14. Update
  15. Results

See a number that looks wrong?